{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:51:40Z","timestamp":1791355900117,"version":"4.3.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T00:00:00Z","timestamp":1478217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T00:00:00Z","timestamp":1478217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1038\/leu.2016.322","type":"journal-article","created":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T03:41:00Z","timestamp":1478230860000},"page":"282-291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":131,"title":["Antigen receptor stereotypy in chronic lymphocytic leukemia"],"prefix":"10.1038","volume":"31","author":[{"given":"K","family":"Stamatopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Agathangelidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Rosenquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Ghia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,4]]},"reference":[{"key":"BFleu2016322_CR1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ajh.23979","volume":"90","author":"M Hallek","year":"2015","unstructured":"Hallek M . Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment. Am J Hematol 2015; 90: 446\u2013460.","journal-title":"Am J Hematol"},{"key":"BFleu2016322_CR2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.semcancer.2015.04.009","volume":"34","author":"LA Sutton","year":"2015","unstructured":"Sutton LA, Rosenquist R . The complex interplay between cell-intrinsic and cell-extrinsic factors driving the evolution of chronic lymphocytic leukemia. Semin Cancer Biol 2015; 34: 22\u201335.","journal-title":"Semin Cancer Biol"},{"key":"BFleu2016322_CR3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.seminhematol.2014.05.004","volume":"51","author":"M Gruber","year":"2014","unstructured":"Gruber M, Wu CJ . Evolving understanding of the CLL genome. Semin Hematol 2014; 51: 177\u2013187.","journal-title":"Semin Hematol"},{"key":"BFleu2016322_CR4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3324\/haematol.2014.115923","volume":"100","author":"LA Sutton","year":"2015","unstructured":"Sutton LA, Rosenquist R . Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution. Haematologica 2015; 100: 7\u201316.","journal-title":"Haematologica"},{"key":"BFleu2016322_CR5","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1200\/JCO.2009.27.8762","volume":"28","author":"T Zenz","year":"2010","unstructured":"Zenz T, Eichhorst B, Busch R, Denzel T, Habe S, Winkler D et al. TP53 mutation and survival in chronic lymphocytic leukemia. J Clin Oncol 2010; 28: 4473\u20134479.","journal-title":"J Clin Oncol"},{"key":"BFleu2016322_CR6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.semcancer.2013.07.006","volume":"23","author":"LA Sutton","year":"2013","unstructured":"Sutton LA, Agathangelidis A, Belessi C, Darzentas N, Davi F, Ghia P et al. Antigen selection in B-cell lymphomas\u2014tracing the evidence. Semin Cancer Biol 2013; 23: 399\u2013409.","journal-title":"Semin Cancer Biol"},{"key":"BFleu2016322_CR7","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.3324\/haematol.2013.098384","volume":"99","author":"G Packham","year":"2014","unstructured":"Packham G, Krysov S, Allen A, Savelyeva N, Steele AJ, Forconi F et al. The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergy. Haematologica 2014; 99: 1138\u20131148.","journal-title":"Haematologica"},{"key":"BFleu2016322_CR8","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.it.2013.07.002","volume":"34","author":"JA Burger","year":"2013","unstructured":"Burger JA, Chiorazzi N . B cell receptor signaling in chronic lymphocytic leukemia. Trends Immunol 2013; 34: 592\u2013601.","journal-title":"Trends Immunol"},{"key":"BFleu2016322_CR9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1146\/annurev.immunol.21.120601.141018","volume":"21","author":"N Chiorazzi","year":"2003","unstructured":"Chiorazzi N, Ferrarini M . B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol 2003; 21: 841\u2013894.","journal-title":"Annu Rev Immunol"},{"key":"BFleu2016322_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa1215637","volume":"369","author":"JC Byrd","year":"2013","unstructured":"Byrd JC, Furman RR, Coutre SE, Flinn IW, Burger JA, Blum KA et al. Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med 2013; 369: 32\u201342.","journal-title":"N Engl J Med"},{"key":"BFleu2016322_CR11","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa1315226","volume":"370","author":"RR Furman","year":"2014","unstructured":"Furman RR, Sharman JP, Coutre SE, Cheson BD, Pagel JM, Hillmen P et al. Idelalisib and rituximab in relapsed chronic lymphocytic leukemia. N Engl J Med 2014; 370: 997\u20131007.","journal-title":"N Engl J Med"},{"key":"BFleu2016322_CR12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.seminhematol.2014.05.003","volume":"51","author":"FK Stevenson","year":"2014","unstructured":"Stevenson FK, Forconi F, Packham G . The meaning and relevance of B-cell receptor structure and function in chronic lymphocytic leukemia. Semin Hematol 2014; 51: 158\u2013167.","journal-title":"Semin Hematol"},{"key":"BFleu2016322_CR13","first-page":"9","volume-title":"Distinct Homotypic B-cell Receptor Interactions Shape The Outcome Of Chronic Lymphocytic Leukemia. 21st Congress of EHA; 2016","author":"M Gounari","year":"2016","unstructured":"Gounari M, Minici C, Ubelhart R, Duehren-von Minden M, Schneider D, Tasdogan A et al. Distinct Homotypic B-cell Receptor Interactions Shape The Outcome Of Chronic Lymphocytic Leukemia. 21st Congress of EHA; 2016. Haematologica: Copenhagen, Denmark, 2016; p. 9."},{"key":"BFleu2016322_CR14","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI3009","volume":"102","author":"F Fais","year":"1998","unstructured":"Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998; 102: 1515\u20131525.","journal-title":"J Clin Invest"},{"key":"BFleu2016322_CR15","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"TJ Hamblin","year":"1999","unstructured":"Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK . Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848\u20131854.","journal-title":"Blood"},{"key":"BFleu2016322_CR16","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"RN Damle","year":"1999","unstructured":"Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840\u20131847.","journal-title":"Blood"},{"key":"BFleu2016322_CR17","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1158\/0008-5472.CAN-14-0630","volume":"74","author":"A Vardi","year":"2014","unstructured":"Vardi A, Agathangelidis A, Sutton LA, Ghia P, Rosenquist R, Stamatopoulos K . Immunogenetic studies of chronic lymphocytic leukemia: revelations and speculations about ontogeny and clinical evolution. Cancer Res 2014; 74: 4211\u20134216.","journal-title":"Cancer Res"},{"key":"BFleu2016322_CR18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1200\/JCO.2013.53.8421","volume":"32","author":"D Mertens","year":"2014","unstructured":"Mertens D, Stilgenbauer S . Prognostic and predictive factors in patients with chronic lymphocytic leukemia: relevant in the era of novel treatment approaches? J Clin Oncol 2014; 32: 869\u2013872.","journal-title":"J Clin Oncol"},{"key":"BFleu2016322_CR19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/leu.2014.196","volume":"29","author":"P Baliakas","year":"2015","unstructured":"Baliakas P, Hadzidimitriou A, Sutton LA, Rossi D, Minga E, Villamor N et al. Recurrent mutations refine prognosis in chronic lymphocytic leukemia. Leukemia 2015; 29: 329\u2013336.","journal-title":"Leukemia"},{"key":"BFleu2016322_CR20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.20040544","volume":"200","author":"BT Messmer","year":"2004","unstructured":"Messmer BT, Albesiano E, Efremov DG, Ghiotto F, Allen SL, Kolitz J et al. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 2004; 200: 519\u2013525.","journal-title":"J Exp Med"},{"key":"BFleu2016322_CR21","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1084\/jem.181.4.1507","volume":"181","author":"S Hashimoto","year":"1995","unstructured":"Hashimoto S, Dono M, Wakai M, Allen SL, Lichtman SM, Schulman P et al. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. J Exp Med 1995; 181: 1507\u20131517.","journal-title":"J Exp Med"},{"key":"BFleu2016322_CR22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4049\/jimmunol.158.1.235","volume":"158","author":"TA Johnson","year":"1997","unstructured":"Johnson TA, Rassenti LZ, Kipps TJ . Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol 1997; 158: 235\u2013246.","journal-title":"J Immunol"},{"key":"BFleu2016322_CR23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0167-5699(94)90009-4","volume":"15","author":"Jr Schroeder HW","year":"1994","unstructured":"Schroeder Jr HW, Dighiero G . The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today 1994; 15: 288\u2013294.","journal-title":"Immunol Today"},{"key":"BFleu2016322_CR24","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2002-11-3485","volume":"101","author":"G Tobin","year":"2003","unstructured":"Tobin G, Thunberg U, Johnson A, Eriksson I, Soderberg O, Karlsson K et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 2003; 101: 4952\u20134957.","journal-title":"Blood"},{"key":"BFleu2016322_CR25","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1172\/JCI19399","volume":"113","author":"F Ghiotto","year":"2004","unstructured":"Ghiotto F, Fais F, Valetto A, Albesiano E, Hashimoto S, Dono M et al. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest 2004; 113: 1008\u20131016.","journal-title":"J Clin Invest"},{"key":"BFleu2016322_CR26","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1182\/blood-2004-07-2606","volume":"105","author":"P Ghia","year":"2005","unstructured":"Ghia P, Stamatopoulos K, Belessi C, Moreno C, Stella S, Guida G et al. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood 2005; 105: 1678\u20131685.","journal-title":"Blood"},{"key":"BFleu2016322_CR27","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1182\/blood-2004-01-0132","volume":"104","author":"G Tobin","year":"2004","unstructured":"Tobin G, Thunberg U, Karlsson K, Murray F, Laurell A, Willander K et al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 2004; 104: 2879\u20132885.","journal-title":"Blood"},{"key":"BFleu2016322_CR28","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1182\/blood-2004-03-0818","volume":"104","author":"GF Widhopf 2nd","year":"2004","unstructured":"Widhopf GF 2nd, Rassenti LZ, Toy TL, Gribben JG, Wierda WG, Kipps TJ . Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 2004; 104: 2499\u20132504.","journal-title":"Blood"},{"key":"BFleu2016322_CR29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood-2006-03-012948","volume":"109","author":"K Stamatopoulos","year":"2007","unstructured":"Stamatopoulos K, Belessi C, Moreno C, Boudjograh M, Guida G, Smilevska T et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 2007; 109: 259\u2013270.","journal-title":"Blood"},{"key":"BFleu2016322_CR30","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1182\/blood-2007-07-099564","volume":"111","author":"F Murray","year":"2008","unstructured":"Murray F, Darzentas N, Hadzidimitriou A, Tobin G, Boudjogra M, Scielzo C et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 2008; 111: 1524\u20131533.","journal-title":"Blood"},{"key":"BFleu2016322_CR31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/j.1460-2075.1992.tb05092.x","volume":"11","author":"PM Kirkham","year":"1992","unstructured":"Kirkham PM, Mortari F, Newton JA, Schroeder HW Jr . Immunoglobulin VH clan and family identity predicts variable domain structure and may influence antigen binding. EMBO J 1992; 11: 603\u2013609.","journal-title":"EMBO J"},{"key":"BFleu2016322_CR32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/leu.2009.186","volume":"24","author":"N Darzentas","year":"2010","unstructured":"Darzentas N, Hadzidimitriou A, Murray F, Hatzi K, Josefsson P, Laoutaris N et al. A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence. Leukemia 2010; 24: 125\u2013132.","journal-title":"Leukemia"},{"key":"BFleu2016322_CR33","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1182\/blood-2011-11-393694","volume":"119","author":"A Agathangelidis","year":"2012","unstructured":"Agathangelidis A, Darzentas N, Hadzidimitriou A, Brochet X, Murray F, Yan XJ et al. Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. Blood 2012; 119: 4467\u20134475.","journal-title":"Blood"},{"key":"BFleu2016322_CR34","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2141.2008.07469.x","volume":"144","author":"R Bomben","year":"2009","unstructured":"Bomben R, Dal Bo M, Capello D, Forconi F, Maffei R, Laurenti L et al. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study. Br J Haematol 2009; 144: 492\u2013506.","journal-title":"Br J Haematol"},{"key":"BFleu2016322_CR35","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1093\/bioinformatics\/btv456","volume":"31","author":"V Bystry","year":"2015","unstructured":"Bystry V, Agathangelidis A, Bikos V, Sutton LA, Baliakas P, Hadzidimitriou A et al. ARResT\/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy. Bioinformatics 2015; 31: 3844\u20133846.","journal-title":"Bioinformatics"},{"key":"BFleu2016322_CR36","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood-2010-07-155663","volume":"117","author":"N Chiorazzi","year":"2011","unstructured":"Chiorazzi N, Ferrarini M . Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood 2011; 117: 1781\u20131791.","journal-title":"Blood"},{"key":"BFleu2016322_CR37","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1084\/jem.20120833","volume":"209","author":"M Seifert","year":"2012","unstructured":"Seifert M, Sellmann L, Bloehdorn J, Wein F, Stilgenbauer S, Durig J et al. Cellular origin and pathophysiology of chronic lymphocytic leukemia. J Exp Med 2012; 209: 2183\u20132198.","journal-title":"J Exp Med"},{"key":"BFleu2016322_CR38","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1084\/jem.20060087","volume":"203","author":"D Paus","year":"2006","unstructured":"Paus D, Phan TG, Chan TD, Gardam S, Basten A, Brink R . Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation. J Exp Med 2006; 203: 1081\u20131091.","journal-title":"J Exp Med"},{"key":"BFleu2016322_CR39","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","volume":"352","author":"N Chiorazzi","year":"2005","unstructured":"Chiorazzi N, Rai KR, Ferrarini M . Chronic lymphocytic leukemia. N Engl J Med 2005; 352: 804\u2013815.","journal-title":"N Engl J Med"},{"key":"BFleu2016322_CR40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.immunol.021908.132607","volume":"27","author":"JC Weill","year":"2009","unstructured":"Weill JC, Weller S, Reynaud CA . Human marginal zone B cells. Annu Rev Immunol 2009; 27: 267\u2013285.","journal-title":"Annu Rev Immunol"},{"key":"BFleu2016322_CR41","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1084\/jem.20120774","volume":"209","author":"CP Chappell","year":"2012","unstructured":"Chappell CP, Draves KE, Giltiay NV, Clark EA . Extrafollicular B cell activation by marginal zone dendritic cells drives T cell-dependent antibody responses. J Exp Med 2012; 209: 1825\u20131840.","journal-title":"J Exp Med"},{"key":"BFleu2016322_CR42","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1084\/jem.20120127","volume":"209","author":"T Kaji","year":"2012","unstructured":"Kaji T, Ishige A, Hikida M, Taka J, Hijikata A, Kubo M et al. Distinct cellular pathways select germline-encoded and somatically mutated antibodies into immunological memory. J Exp Med 2012; 209: 2079\u20132097.","journal-title":"J Exp Med"},{"key":"BFleu2016322_CR43","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1172\/JCI24387","volume":"115","author":"M Herve","year":"2005","unstructured":"Herve M, Xu K, Ng YS, Wardemann H, Albesiano E, Messmer BT et al. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J Clin Invest 2005; 115: 1636\u20131643.","journal-title":"J Clin Invest"},{"key":"BFleu2016322_CR44","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2119\/2008-00102.Catera","volume":"14","author":"R Catera","year":"2008","unstructured":"Catera R, Silverman GJ, Hatzi K, Seiler T, Didier S, Zhang L et al. Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation. Mol Med 2008; 14: 665\u2013674.","journal-title":"Mol Med"},{"key":"BFleu2016322_CR45","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1182\/blood.V76.3.562.562","volume":"76","author":"L Borche","year":"1990","unstructured":"Borche L, Lim A, Binet JL, Dighiero G . Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. Blood 1990; 76: 562\u2013569.","journal-title":"Blood"},{"key":"BFleu2016322_CR46","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1182\/blood-2008-06-162024","volume":"112","author":"CC Chu","year":"2008","unstructured":"Chu CC, Catera R, Hatzi K, Yan XJ, Zhang L, Wang XB et al. Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA. Blood 2008; 112: 5122\u20135129.","journal-title":"Blood"},{"key":"BFleu2016322_CR47","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood-2007-11-125450","volume":"111","author":"A Lanemo Myhrinder","year":"2008","unstructured":"Lanemo Myhrinder A, Hellqvist E, Sidorova E, Soderberg A, Baxendale H, Dahle C et al. A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood 2008; 111: 3838\u20133848.","journal-title":"Blood"},{"key":"BFleu2016322_CR48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.20121801","volume":"210","author":"R Hoogeboom","year":"2013","unstructured":"Hoogeboom R, van Kessel KP, Hochstenbach F, Wormhoudt TA, Reinten RJ, Wagner K et al. A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi. J Exp Med 2013; 210: 59\u201370.","journal-title":"J Exp Med"},{"key":"BFleu2016322_CR49","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00281-004-0182-2","volume":"26","author":"N Baumgarth","year":"2005","unstructured":"Baumgarth N, Tung JW, Herzenberg LA . Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin Immunopathol 2005; 26: 347\u2013362.","journal-title":"Springer Semin Immunopathol"},{"key":"BFleu2016322_CR50","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2901","volume":"11","author":"N Baumgarth","year":"2011","unstructured":"Baumgarth N . The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol 2011; 11: 34\u201346.","journal-title":"Nat Rev Immunol"},{"key":"BFleu2016322_CR51","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1172\/JCI36800","volume":"119","author":"MY Chou","year":"2009","unstructured":"Chou MY, Fogelstrand L, Hartvigsen K, Hansen LF, Woelkers D, Shaw PX et al. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest 2009; 119: 1335\u20131349.","journal-title":"J Clin Invest"},{"key":"BFleu2016322_CR52","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.4049\/jimmunol.177.5.2749","volume":"177","author":"RR Hardy","year":"2006","unstructured":"Hardy RR . B-1 B cell development. J Immunol 2006; 177: 2749\u20132754.","journal-title":"J Immunol"},{"key":"BFleu2016322_CR53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4614-6217-0_7","volume":"785","author":"N Baumgarth","year":"2013","unstructured":"Baumgarth N . Innate-like B cells and their rules of engagement. Adv Exp Med Biol 2013; 785: 57\u201366.","journal-title":"Adv Exp Med Biol"},{"key":"BFleu2016322_CR54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1084\/jem.20101499","volume":"208","author":"DO Griffin","year":"2011","unstructured":"Griffin DO, Holodick NE, Rothstein TL . Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70. J Exp Med 2011; 208: 67\u201380.","journal-title":"J Exp Med"},{"key":"BFleu2016322_CR55","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nri799","volume":"2","author":"F Martin","year":"2002","unstructured":"Martin F, Kearney JF . Marginal-zone B cells. Nat Rev Immunol 2002; 2: 323\u2013335.","journal-title":"Nat Rev Immunol"},{"key":"BFleu2016322_CR56","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00281-004-0188-9","volume":"26","author":"EC Milner","year":"2005","unstructured":"Milner EC, Anolik J, Cappione A, Sanz I . Human innate B cells: a link between host defense and autoimmunity? Springer Semin Immunopathol 2005; 26: 433\u2013452.","journal-title":"Springer Semin Immunopathol"},{"key":"BFleu2016322_CR57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood-2009-06-225813","volume":"115","author":"F Forconi","year":"2010","unstructured":"Forconi F, Potter KN, Wheatley I, Darzentas N, Sozzi E, Stamatopoulos K et al. The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL. Blood 2010; 115: 71\u201377.","journal-title":"Blood"},{"key":"BFleu2016322_CR58","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1182\/blood-2011-03-343434","volume":"118","author":"A Hadzidimitriou","year":"2011","unstructured":"Hadzidimitriou A, Agathangelidis A, Darzentas N, Murray F, Delfau-Larue MH, Pedersen LB et al. Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases. Blood 2011; 118: 3088\u20133095.","journal-title":"Blood"},{"key":"BFleu2016322_CR59","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.3324\/haematol.2010.025437","volume":"95","author":"S Zibellini","year":"2010","unstructured":"Zibellini S, Capello D, Forconi F, Marcatili P, Rossi D, Rattotti S et al. Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. Haematologica 2010; 95: 1792\u20131796.","journal-title":"Haematologica"},{"key":"BFleu2016322_CR60","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/leu.2012.3","volume":"26","author":"V Bikos","year":"2012","unstructured":"Bikos V, Darzentas N, Hadzidimitriou A, Davis Z, Hockley S, Traverse-Glehen A et al. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications. Leukemia 2012; 26: 1638\u20131646.","journal-title":"Leukemia"},{"key":"BFleu2016322_CR61","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/leu.2011.311","volume":"26","author":"E Kostareli","year":"2012","unstructured":"Kostareli E, Gounari M, Janus A, Murray F, Brochet X, Giudicelli V et al. Antigen receptor stereotypy across B-cell lymphoproliferations: the case of IGHV4-59\/IGKV3-20 receptors with rheumatoid factor activity. Leukemia 2012; 26: 1127\u20131131.","journal-title":"Leukemia"},{"key":"BFleu2016322_CR62","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3324\/haematol.11872","volume":"93","author":"A Athanasiadou","year":"2008","unstructured":"Athanasiadou A, Stamatopoulos K, Gaitatzi M, Stavroyianni N, Fassas A, Anagnostopoulos A . Recurrent cytogenetic findings in subsets of patients with chronic lymphocytic leukemia expressing IgG-switched stereotyped immunoglobulins. Haematologica 2008; 93: 473\u2013474.","journal-title":"Haematologica"},{"key":"BFleu2016322_CR63","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3324\/haematol.2009.021014","volume":"95","author":"M Marincevic","year":"2010","unstructured":"Marincevic M, Cahill N, Gunnarsson R, Isaksson A, Mansouri M, Goransson H et al. High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with \u2018stereotyped\u2019 IGHV3-21 and IGHV4-34 B-cell receptors. Haematologica 2010; 95: 1519\u20131525.","journal-title":"Haematologica"},{"key":"BFleu2016322_CR64","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4161\/epi.22901","volume":"7","author":"M Kanduri","year":"2012","unstructured":"Kanduri M, Marincevic M, Halldorsdottir AM, Mansouri L, Junevik K, Ntoufa S et al. Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles. Epigenetics 2012; 7: 1435\u20131442.","journal-title":"Epigenetics"},{"key":"BFleu2016322_CR65","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3324\/haematol.2010.028639","volume":"95","author":"M Marincevic","year":"2010","unstructured":"Marincevic M, Mansouri M, Kanduri M, Isaksson A, Goransson H, Smedby KE et al. Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors. Haematologica 2010; 95: 2072\u20132079.","journal-title":"Haematologica"},{"key":"BFleu2016322_CR66","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2119\/molmed.2013.00005","volume":"19","author":"N Papakonstantinou","year":"2013","unstructured":"Papakonstantinou N, Ntoufa S, Chartomatsidou E, Papadopoulos G, Hatzigeorgiou A, Anagnostopoulos A et al. Differential microRNA profiles and their functional implications in different immunogenetic subsets of chronic lymphocytic leukemia. Mol Med 2013; 19: 115\u2013123.","journal-title":"Mol Med"},{"key":"BFleu2016322_CR67","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2119\/molmed.2011.00480","volume":"18","author":"S Ntoufa","year":"2012","unstructured":"Ntoufa S, Vardi A, Papakonstantinou N, Anagnostopoulos A, Aleporou-Marinou V, Belessi C et al. Distinct innate immunity pathways to activation and tolerance in subgroups of chronic lymphocytic leukemia with distinct immunoglobulin receptors. Mol Med 2012; 18: 1281\u20131291.","journal-title":"Mol Med"},{"key":"BFleu2016322_CR68","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1182\/blood-2014-09-603217","volume":"125","author":"M Gounari","year":"2015","unstructured":"Gounari M, Ntoufa S, Apollonio B, Papakonstantinou N, Ponzoni M, Chu CC et al. Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8. Blood 2015; 125: 3580\u20133587.","journal-title":"Blood"},{"key":"BFleu2016322_CR69","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.4049\/jimmunol.1502297","volume":"196","author":"S Ntoufa","year":"2016","unstructured":"Ntoufa S, Papakonstantinou N, Apollonio B, Gounari M, Galigalidou C, Fonte E et al. B Cell Anergy Modulated by TLR1\/2 and the miR-17 approximately 92 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4. J Immunol 2016; 196: 4410\u20134417.","journal-title":"J Immunol"},{"key":"BFleu2016322_CR70","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ajh.23591","volume":"89","author":"I Del Giudice","year":"2014","unstructured":"Del Giudice I, Chiaretti S, Santangelo S, Tavolaro S, Peragine N, Marinelli M et al. Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients\u2019 prognosis. Am J Hematol 2014; 89: 74\u201382.","journal-title":"Am J Hematol"},{"key":"BFleu2016322_CR71","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1126\/science.1165395","volume":"322","author":"S Varambally","year":"2008","unstructured":"Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 2008; 322: 1695\u20131699.","journal-title":"Science"},{"key":"BFleu2016322_CR72","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","volume":"23","author":"W Beguelin","year":"2013","unstructured":"Beguelin W, Popovic R, Teater M, Jiang Y, Bunting KL, Rosen M et al. EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer cell 2013; 23: 677\u2013692.","journal-title":"Cancer cell"},{"key":"BFleu2016322_CR73","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.4161\/epi.26546","volume":"8","author":"M Kanduri","year":"2013","unstructured":"Kanduri M, Sander B, Ntoufa S, Papakonstantinou N, Sutton LA, Stamatopoulos K et al. A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma. Epigenetics 2013; 8: 1280\u20131288.","journal-title":"Epigenetics"},{"key":"BFleu2016322_CR74","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/bjc.2011.551","volume":"106","author":"CJ Chang","year":"2012","unstructured":"Chang CJ, Hung MC . The role of EZH2 in tumour progression. Br J Cancer 2012; 106: 243\u2013247.","journal-title":"Br J Cancer"},{"key":"BFleu2016322_CR75","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3324\/haematol.2016.141812","volume":"101","author":"LA Sutton","year":"2016","unstructured":"Sutton LA, Young E, Baliakas P, Hadzidimitriou A, Moysiadis T, Plevova K et al. Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors. Haematologica 2016; 101: 959\u2013967.","journal-title":"Haematologica"},{"key":"BFleu2016322_CR76","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1084\/jem.20142009","volume":"212","author":"L Mansouri","year":"2015","unstructured":"Mansouri L, Sutton LA, Ljungstrom V, Bondza S, Arngarden L, Bhoi S et al. Functional loss of IkappaBepsilon leads to NF-kappaB deregulation in aggressive chronic lymphocytic leukemia. J Exp Med 2015; 212: 833\u2013843.","journal-title":"J Exp Med"},{"key":"BFleu2016322_CR77","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1182\/blood-2014-09-600874","volume":"125","author":"P Baliakas","year":"2015","unstructured":"Baliakas P, Agathangelidis A, Hadzidimitriou A, Sutton LA, Minga E, Tsanousa A et al. Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations. Blood 2015; 125: 856\u2013859.","journal-title":"Blood"},{"key":"BFleu2016322_CR78","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1182\/blood-2008-07-166868","volume":"113","author":"A Hadzidimitriou","year":"2009","unstructured":"Hadzidimitriou A, Darzentas N, Murray F, Smilevska T, Arvaniti E, Tresoldi C et al. Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia. Blood 2009; 113: 403\u2013411.","journal-title":"Blood"},{"key":"BFleu2016322_CR79","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1002\/eji.200535751","volume":"36","author":"CJ Belessi","year":"2006","unstructured":"Belessi CJ, Davi FB, Stamatopoulos KE, Degano M, Andreou TM, Moreno C et al. IGHV gene insertions and deletions in chronic lymphocytic leukemia: \u2018CLL-biased\u2019 deletions in a subset of cases with stereotyped receptors. Eur J Immunol 2006; 36: 1963\u20131974.","journal-title":"Eur J Immunol"},{"key":"BFleu2016322_CR80","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/bjh.12893","volume":"166","author":"J Malcikova","year":"2014","unstructured":"Malcikova J, Stalika E, Davis Z, Plevova K, Trbusek M, Mansouri L et al. The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors. Br J Haematol 2014; 166: 621\u2013625.","journal-title":"Br J Haematol"},{"key":"BFleu2016322_CR81","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/S2352-3026(14)00005-2","volume":"1","author":"P Baliakas","year":"2014","unstructured":"Baliakas P, Hadzidimitriou A, Sutton LA, Minga E, Agathangelidis A, Nichelatti M et al. Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study. Lancet Haematol 2014; 1: e74\u2013e84.","journal-title":"Lancet Haematol"},{"key":"BFleu2016322_CR82","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2013-02-486209","volume":"121","author":"D Rossi","year":"2013","unstructured":"Rossi D, Spina V, Bomben R, Rasi S, Dal-Bo M, Bruscaggin A et al. Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia. Blood 2013; 121: 4902\u20134905.","journal-title":"Blood"},{"key":"BFleu2016322_CR83","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1038\/leu.2013.98","volume":"27","author":"JC Strefford","year":"2013","unstructured":"Strefford JC, Sutton LA, Baliakas P, Agathangelidis A, Malcikova J, Plevova K et al. Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2. Leukemia 2013; 27: 2196\u20132199.","journal-title":"Leukemia"},{"key":"BFleu2016322_CR84","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1093\/emboj\/19.23.6569","volume":"19","author":"P Ajuh","year":"2000","unstructured":"Ajuh P, Kuster B, Panov K, Zomerdijk JC, Mann M, Lamond AI . Functional analysis of the human CDC5L complex and identification of its components by mass spectrometry. EMBO J 2000; 19: 6569\u20136581.","journal-title":"EMBO J"},{"key":"BFleu2016322_CR85","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1182\/blood-2011-08-373159","volume":"118","author":"D Rossi","year":"2011","unstructured":"Rossi D, Bruscaggin A, Spina V, Rasi S, Khiabanian H, Messina M et al. Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. Blood 2011; 118: 6904\u20136908.","journal-title":"Blood"},{"key":"BFleu2016322_CR86","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","volume":"343","author":"H Dohner","year":"2000","unstructured":"Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910\u20131916.","journal-title":"N Engl J Med"},{"key":"BFleu2016322_CR87","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1158\/1078-0432.CCR-13-1993","volume":"20","author":"A Vardi","year":"2014","unstructured":"Vardi A, Agathangelidis A, Sutton LA, Chatzouli M, Scarfo L, Mansouri L et al. IgG-switched CLL has a distinct immunogenetic signature from the common MD variant: ontogenetic implications. Clin Cancer Res 2014; 20: 323\u2013330.","journal-title":"Clin Cancer Res"},{"key":"BFleu2016322_CR88","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s000180300026","volume":"60","author":"YJ Jang","year":"2003","unstructured":"Jang YJ, Stollar BD . Anti-DNA antibodies: aspects of structure and pathogenicity. Cell Mol Life Sci 2003; 60: 309\u2013320.","journal-title":"Cell Mol Life Sci"},{"key":"BFleu2016322_CR89","doi-asserted-by":"crossref","first-page":"4460","DOI":"10.1182\/blood-2009-05-221309","volume":"114","author":"LA Sutton","year":"2009","unstructured":"Sutton LA, Kostareli E, Hadzidimitriou A, Darzentas N, Tsaftaris A, Anagnostopoulos A et al. Extensive intraclonal diversification in a subgroup of chronic lymphocytic leukemia patients with stereotyped IGHV4-34 receptors: implications for ongoing interactions with antigen. Blood 2009; 114: 4460\u20134468.","journal-title":"Blood"},{"key":"BFleu2016322_CR90","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/leu.2010.90","volume":"24","author":"E Kostareli","year":"2010","unstructured":"Kostareli E, Sutton LA, Hadzidimitriou A, Darzentas N, Kouvatsi A, Tsaftaris A et al. Intraclonal diversification of immunoglobulin light chains in a subset of chronic lymphocytic leukemia alludes to antigen-driven clonal evolution. Leukemia 2010; 24: 1317\u20131324.","journal-title":"Leukemia"},{"key":"BFleu2016322_CR91","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2119\/molmed.2013.00042","volume":"19","author":"LA Sutton","year":"2013","unstructured":"Sutton LA, Kostareli E, Stalika E, Tsaftaris A, Anagnostopoulos A, Darzentas N et al. Temporal dynamics of clonal evolution in chronic lymphocytic leukemia with stereotyped IGHV4-34\/IGKV2-30 antigen receptors: longitudinal immunogenetic evidence. Mol Med 2013; 19: 230\u2013236.","journal-title":"Mol Med"},{"key":"BFleu2016322_CR92","doi-asserted-by":"crossref","first-page":"720","DOI":"10.2119\/molmed.2014.00140","volume":"20","author":"LA Sutton","year":"2014","unstructured":"Sutton LA, Papadopoulos G, Hadzidimitriou A, Papadopoulos S, Kostareli E, Rosenquist R et al. An entity evolving into a community: defining the common ancestor and evolutionary trajectory of chronic lymphocytic leukemia stereotyped subset #4. Mol Med 2014; 20: 720\u2013728.","journal-title":"Mol Med"},{"key":"BFleu2016322_CR93","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2007-09-111344","volume":"112","author":"M Muzio","year":"2008","unstructured":"Muzio M, Apollonio B, Scielzo C, Frenquelli M, Vandoni I, Boussiotis V et al. Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy. Blood 2008; 112: 188\u2013195.","journal-title":"Blood"},{"key":"BFleu2016322_CR94","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1158\/1078-0432.CCR-08-3266","volume":"15","author":"D Rossi","year":"2009","unstructured":"Rossi D, Spina V, Cerri M, Rasi S, Deambrogi C, De Paoli L et al. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clin Cancer Res 2009; 15: 4415\u20134422.","journal-title":"Clin Cancer Res"},{"key":"BFleu2016322_CR95","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/joim.12455","volume":"279","author":"P Baliakas","year":"2016","unstructured":"Baliakas P, Mattsson M, Stamatopoulos K, Rosenquist R . Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed? J Int Med 2016; 279: 347\u2013357.","journal-title":"J Int Med"},{"key":"BFleu2016322_CR96","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.3109\/10428194.2013.783913","volume":"54","author":"R Rosenquist","year":"2013","unstructured":"Rosenquist R, Cortese D, Bhoi S, Mansouri L, Gunnarsson R . Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand? Leuk Lymphoma 2013; 54: 2351\u20132364.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2016322_CR97","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1182\/blood-2005-06-2227","volume":"107","author":"M Thorselius","year":"2006","unstructured":"Thorselius M, Krober A, Murray F, Thunberg U, Tobin G, Buhler A et al. Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status. Blood 2006; 107: 2889\u20132894.","journal-title":"Blood"},{"key":"BFleu2016322_CR98","doi-asserted-by":"crossref","first-page":"e24313","DOI":"10.1371\/journal.pone.0024313","volume":"6","author":"F Maura","year":"2011","unstructured":"Maura F, Cutrona G, Fabris S, Colombo M, Tuana G, Agnelli L et al. Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia. PLoS One 2011; 6: e24313.","journal-title":"PLoS One"},{"key":"BFleu2016322_CR99","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1182\/blood-2007-12-130229","volume":"111","author":"EM Ghia","year":"2008","unstructured":"Ghia EM, Jain S, Widhopf GF 2nd, Rassenti LZ, Keating MJ, Wierda WG et al. Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection. Blood 2008; 111: 5101\u20135108.","journal-title":"Blood"},{"key":"BFleu2016322_CR100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ajh.23618","volume":"89","author":"P Baliakas","year":"2014","unstructured":"Baliakas P, Iskas M, Gardiner A, Davis Z, Plevova K, Nguyen-Khac F et al. Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data. Am J Hematol 2014; 89: 249\u2013255.","journal-title":"Am J Hematol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2016322.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2016322","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2016322.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T15:10:40Z","timestamp":1692544240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2016322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,4]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["BFleu2016322"],"URL":"https:\/\/doi.org\/10.1038\/leu.2016.322","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,4]]},"assertion":[{"value":"26 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}